Tuesday, November 8, 2016
Category: Immunocompromised Host, Pharmacotherapy
Dr. Yanina Pasikhova discusses the use of trimethoprim/sulfamethoxasole in the treatment of Nocardiosis in hematopoietic stem cell transplant patients. She utilizes a case-based format to highlight the typical risk factors, presentation, and management of nocardia disease in at-risk patients.
Stay in touch! Download our app in the iTunes store or the Google Marketplace.